Search Results - "Parsons, Lori S."

Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock by Chen, Edmond W, Canto, John G, Parsons, Lori S, Peterson, Eric D, Littrell, Katherine A, Every, Nathan R, Gibson, C Michael, Hochman, Judith S, Ohman, E Magnus, Cheeks, Morris, Barron, Hal V

“…Increasing evidence suggests an inverse relationship between outcome and the total number of invasive cardiac procedures performed at a given hospital. The…”
Get full text

Diabetes Mellitus and Trends in Hospital Survival After Myocardial Infarction, 1994 to 2006: Data From the National Registry of Myocardial Infarction by GORE, M. Odette, PATEL, Mahesh J, KOSIBOROD, Mikhail, PARSONS, Lori S, KHERA, Amit, DE LEMOS, James A, ROGERS, William J, PETERSON, Eric D, CANTO, John C, MCGUIRE, Darren K

“…Patients with diabetes mellitus (DM) are at high risk for mortality after myocardial infarction (MI). Despite an overall trend of reduced mortality after MI,…”
Get full text

Use of lipid-lowering medications at discharge in patients with acute myocardial Infarction: Data from the National Registry of Myocardial Infarction 3 by FONAROW, Gregg C, FRENCH, William J, PARSONS, Lori S, HAILI SUN, MALMGREN, Judith A

“…The present study aimed to assess use of lipid-lowering medication at discharge in a current national sample of patients hospitalized with acute myocardial…”
Get full text

Early use of Glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: Observations from the national registry of myocardial infarction 4 by PETERSON, Eric D, POLLACK, Charles V, ROE, T. Matthew T, PARSONS, Lori S, LITTRELL, Katherine A, CANTO, John G, BARRON, Hal V, STONE, Peter H, YEGHIAZARIANS, Yerem

“…We sought to identify patient and hospital features associated with early glycoprotein (GP) IIb/IIIa inhibitor therapy for non-ST-elevation (NSTE) myocardial…”
Get full text

A Comparison of Thrombolytic Therapy with Primary Coronary Angioplasty for Acute Myocardial Infarction by Every, Nathan R, Parsons, Lori S, Hlatky, Mark, Martin, Jenny S, Weaver, W. Douglas

“…Several randomized, controlled trials have shown that the short-term outcome in patients with acute myocardial infarction is better after primary angioplasty…”
Get full text

Survival in Pulmonary Hypertension Registries: Response by Chung, Lorinda, MD, Liu, Juliana, MSN, Parsons, Lori S., BS, Hassoun, Paul M., MD, FCCP, McGoon, Michael D., MD, FCCP, Badesch, David B., MD, FCCP, Miller, Dave P., MS, Nicolls, Mark R., MD, Zamanian, Roham T., MD

Get full text

Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 study by Krumholz, Harlan M, Gross, Cary P, Peterson, Eric D, Barron, Hal V, Radford, Martha J, Parsons, Lori S, Every, Nathan R

“…Some experts have raised concerns about the ability to generalize randomized trials, emphasizing that patients who participate in these studies are often not…”
Get full text

Effectiveness and Safety of Glycoprotein IIb/IIIa Inhibitors and Clopidogrel Alone and in Combination in Non–ST-Segment Elevation Myocardial Infarction (from the National Registry of Myocardial Infarction-4) by Bromberg-Marin, Guilherme, Marin-Neto, Jose A., Parsons, Lori S., Canto, John G., Rogers, William J.

“…We investigated whether a combination of clopidogrel and glycoprotein (GP) IIb/IIIa inhibitors safely decreases hospital mortality, reinfarction, and major…”
Get full text

Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction by SANDERS, Gillian D, HLATKY, Mark A, EVERY, Nathan R, MCDONALD, Kathryn M, HEIDENREICH, Paul A, PARSONS, Lori S, OWENS, Douglas K

“…Clinical trials have shown that implantable cardioverter defibrillators (ICDs) improve survival in patients with sustained ventricular arrhythmias. To…”
Get full text

Primary angioplasty and selection bias in patients presenting late (>12 h) after onset of chest pain and ST elevation myocardial infarction by ELAD, Yaron, FRENCH, William J, SHAVELLE, David M, PARSONS, Lori S, SADA, Mark J, EVERY, Nathan R

Get full text

Quality of care by classification of myocardial infarction: treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarction by Roe, Matthew T, Parsons, Lori S, Pollack, Jr, Charles V, Canto, John G, Barron, Hal V, Every, Nathan R, Rogers, William J, Peterson, Eric D

“…Practice guidelines for acute ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) recommend similar therapies and interventions, but…”
Get more information

Long-term outcome in acute myocardial infarction patients admitted to hospitals with and without on-site cardiac catheterization facilities by EVERY, N. R, PARSONS, L. S, FIHN, S. D, LARSON, E. B, MAYNARD, C, HALLSTROM, A. P, MARTIN, J. S, WEAVER, W. D

“…Background Previous studies have documented the strong association between availability of on-site cardiac catheterization facilities and increased use of…”
Get full text

Does enrollment in a randomized clinical trial lead to a higher cost of routine care? by Weiss, J.Peter, Parsons, Lori S., Every, Nathan R., Weaver, W.Douglas, Hlatky, Mark A.

“…Background Reimbursement for the routine care of patients enrolled in clinical trials is controversial. Our objective was to determine the added medical costs,…”
Get full text

The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2 by Barron, Hal V., Every, Nathan R., Parsons, Lori S., Angeja, Brad, Goldberg, Robert J., Gore, Joel M., Chou, Tony M.

“…Background Cardiogenic shock complicating acute myocardial infarction (AMI) remains the leading cause of death in patients hospitalized with AMI. Although…”
Get full text

Unique Predictors of Mortality in Patients With Pulmonary Arterial Hypertension Associated With Systemic Sclerosis in the REVEAL Registry by Chung, Lorinda, MD, Farber, Harrison W., MD, FCCP, Benza, Raymond, MD, Miller, Dave P., MS, Parsons, Lori, BS, Hassoun, Paul M., MD, FCCP, McGoon, Michael, MD, FCCP, Nicolls, Mark R., MD, Zamanian, Roham T., MD

“…Abstract BACKGROUND: Patients with pulmonary arterial hypertension (PAH) associated with systemic sclerosis (SSc-APAH) experience higher mortality rates than…”
Get full text

Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery : a report from the coronary artery surgery study (CASS) registry by BELL, M. R, GERSH, B. J, SCHAFF, H. V, HOLMES, D. R, ALDERMAN, E. L, MYERS, W. O, PARSONS, L. S, REEDER, G. S

“…Complete revascularization after coronary artery bypass surgery is a logical goal and improves symptomatic outcome and survival. However, the impact of…”
Get full text

Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006 by Peterson, Eric D., MD, MPH, Shah, Bimal R., MD, MBA, Parsons, Lori, BS, Pollack, Charles V., MA, MD, French, William J., MD, Canto, John G., MD, Gibson, C. Michael, MS, MD, Rogers, William J., MD

“…Background Trends in the use of guideline-based treatment for acute myocardial infarction (AMI) as well as its association with patient outcomes have not been…”
Get full text

Early use of glycoprotein IIb/IIIa inhibitors in non–ST-elevation acute myocardial infarction by Peterson, Eric D, Pollack, Charles V, Roe, Matthew T, Parsons, Lori S, Littrell, Katherine A, Canto, John G, Barron, Hal V

“…We sought to identify patient and hospital features associated with early glycoprotein (GP) IIb/IIIa inhibitor therapy for non–ST-elevation (NSTE) myocardial…”
Get full text

827-3 Women with diabetes mellitus have the greatest reduction in myocardial infarction mortality over the past decade: Evaluation of 1,428,596 patients enrolled in the national registry of myocardial infarction 2, 3, and 4 from 1994–2002 by McGuire, Darren K, Khera, Amit, de Lemos, James A, Peterson, Eric D, Warner, John J, Parsons, Lori S, Rogers, William J, Canto, John G, National Registry of Myocardial Infarctions Investigators

Get full text

Primary angioplasty and selection bias inpatients presenting late (>12 h) after onset of chest pain and ST elevation myocardial infarction by Elad, Yaron, French, William J, Shavelle, David M, Parsons, Lori S, Sada, Mark J, Every, Nathan R

“…This study was designed to compare the in-hospital outcome of patients presenting with >12 h from onset of chest pain and acute ST elevation myocardial…”
Get full text